Daily Medication Pearl: Aggrenox (Aspirin/ER, Dipyridamole)

Article

Aggrenox is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

Medication Pearl of the Day: Aggrenox (Aspirin/ER, Dipyridamole)

Indication: Aggrenox is a combination antiplatelet agent indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

Aggrenox reduces the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

Aggrenox

Insight:

  • Dosing: One capsule twice daily (morning and evening) with or without food.
  • Dosage forms: Capsule 25 mg aspirin/200 mg extended-release dipyridamole.
  • Adverse events (AEs): The most frequently reported AEs (>10% and greater than placebo) were headache, dyspepsia, abdominal pain, nausea, and diarrhea.
  • Mechanism of action: The antithrombotic action of Aggrenox is the result of the additive antiplatelet effects of dipyridamole and aspirin.
  • Manufacturer: Boehringer Ingelheim

Sources:

Related Videos
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
Image Credit: © javier - stock.adobe.com
Opill manufacturing | Perrigo
Healthy food selection - Image credit: Alexander Raths | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.